openPR Logo
Press release

Clinical Trial Supplies Market worth $2.9 billion by 2026 - Leading Key Players are Thermo Fisher Scientific (US), Catalent Inc. (US), Parexel (US)

07-29-2021 11:57 AM CET | Health & Medicine

Press release from: MarketsandMarkets™ INC.

Clinical Trial Supplies Market

Clinical Trial Supplies Market

According to the new market research report "Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics, Distribution), Phases (I to IV), Type (Small molecule, Biologics, Medical Devices) Therapeutic Areas (Oncology, CNS, CVD, Infectious, Immunology) - Global Forecast 2026", published by MarketsandMarkets™, the global market is projected to reach USD 2.9 billion by 2026 from USD 1.9 billion in 2021, at a CAGR of 8.5% during the forecast period of 2021 to 2026.

Browse in-depth TOC on "Clinical Trial Supplies Market"
237 – Tables
47 – Figures
242 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=172240059&utm_source=openpr&utm_medium=referral&utm_campaign=paidpr

The market growth is largely driven by the increasing R&D expenditure in pharmaceutical and biopharmaceutical companies and the growing number of clinical trials conducted globally. However, the increasing cost of drug development and clinical trials is expected to restrain the growth of this market during the forecast period.

The logistics and distribution segment accounted for the largest share of the services segment in the clinical trial supplies market in 2020.

Based on the service, the market is segmented into manufacturing; packaging, labeling, and blinding; comparator sourcing; logistics & distribution; storage & retention; and other services. Logistics & distribution services accounted for a share of around 26%. This segment is estimated to grow at the highest CAGR during the forecast period. Logistics & distribution and storage & retention are seen to be the leading segments with respect to the growth rate during the forecast period as a result of greater reliance on decentralization of clinical trials.

The oncology segment accounted for the largest share of the therapeutic area segment in the market in 2020

Based on the therapeutic area, the clinical trial supplies market is segmented into oncology, CNS & mental disorders, cardiovascular diseases, digestive disorders, infectious diseases, metabolic disorders, immunology, blood disorders, and other therapeutic areas (respiratory disorders, dermatological disorders, rare diseases, ENT diseases, Nephrology) Oncology is the largest segment in this market owing to the high and growing number of research studies on cancer therapeutics and the increasing number of companies focusing on bringing innovative cancer drugs into the market. The oncology segment is projected to grow at the highest CAGR during the forecast period.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=172240059&utm_source=openpr&utm_medium=referral&utm_campaign=paidpr

The Asia Pacific region is the fastest-growing region of the clinical trial supplies market in 2020.

Based on the region, the market is broadly segmented into North America, Europe, the Asia Pacific, and the Rest of the World. The huge population base, presence of less stringent and harmonized regulatory frameworks, and limited competition make patient recruitment and seeking approval for clinical trials more convenient, less time-consuming, and cost-efficient in the APAC region. This is attracting the attention of a majority of pharmaceutical, biopharmaceutical, and biotechnology giants to consider conducting their clinical trials in APAC countries. The Asia Pacific market is projected to register the highest growth during the forecast period due to the presence of many emerging players, less-stringent regulations, and the ease and cost-effectiveness of patient recruitment in APAC countries.

The global clinical trial supplies market is competitive. Prominent players operating in the global market include Catalent, Inc. (US), Thermo Fisher Scientific (US), Piramal Pharma Solutions (India), Parexel International Corporation (US), and UDG Healthcare (Ireland).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=172240059&utm_source=openpr&utm_medium=referral&utm_campaign=paidpr

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Trial Supplies Market worth $2.9 billion by 2026 - Leading Key Players are Thermo Fisher Scientific (US), Catalent Inc. (US), Parexel (US) here

News-ID: 2340764 • Views:

More Releases from MarketsandMarkets™ INC.

Electric Vehicle Market Size, Share, Trends & Analysis by 2030
Electric Vehicle Market Size, Share, Trends & Analysis by 2030
The global EV market is projected to grow from USD 388.1 billion in 2023 to USD 951.9 billion by 2030, registering a CAGR of 13.7%. The electric vehicle (EV) market is currently experiencing a transformative phase of rapid growth and innovation. With increasing global concern over climate change and air pollution, coupled with advancements in technology and supportive government policies, the adoption of EVs has gained tremendous momentum. Consumers are
Automotive Radar Market Valued at $33.6 billion by 2030
Automotive Radar Market Valued at $33.6 billion by 2030
The global automotive radar market is projected to grow from USD 6.6 billion in 2024 to USD 33.6 billion by 2030, registering a CAGR of 31.1%. The automotive radar market is flourishing due to a confluence of factors. The primary driver is the surging demand for Advanced Driver-Assistance Systems (ADAS) and autonomous vehicles. These technologies heavily rely on radar for object detection and measurement, making it an essential component. Furthermore, stricter
Connected Car Market Poised to Reach $26.4 billion by 2030
Connected Car Market Poised to Reach $26.4 billion by 2030
The globally connected car market is estimated to grow from USD 12.4 billion in 2024 to USD 26.4 billion by 2030, at a CAGR of 13.3%. Government initiatives towards developing intelligent transportation networks and the growing trend of in-vehicle connectivity solutions are two factors influencing the growth of the worldwide connected car market. Also, the consumer demand for a safer, more convenient, and entertaining driving experience is a significant driver. This
Semi-Autonomous & Autonomous Trucks and Buses Market worth $179.9 billion by 2035
Semi-Autonomous & Autonomous Trucks and Buses Market worth $179.9 billion by 203 …
The Semi-autonomous & autonomous Trucks and Buses market size is projected to grow from USD 40.7 Billion in 2024 to USD 179.9 Billion by 2035, at a CAGR of 14.4%. The increasing demand for electric and autonomous vehicle and government regulation regarding safety is expected to increase the demand for Semi-autonomous & autonomous Trucks and Buses. Additionally, continuos innovation in advance driving technologies and components will boost the demand

All 4 Releases


More Releases for Clinical

Miami Clinical Research Sets the Standard for Clinical Trials
Miami Clinical Research, a frontrunner in the world of clinical trials and medical research, has emerged as the prime choice for global corporate pharmaceutical giants. With a deep understanding of the complexities of medical studies, the organization champions the crucial role of research in the evolution of transformative therapeutic interventions. Miami, FL - Renowned as a first-rate center for professional medical exploration, Miami Clinical Research [https://miamiclinicalresearch.com] boasts state-of-the-art facilities, advanced technologies,
E-Clinical Solutions Market: Revolutionizing Healthcare and Clinical Trials
Introduction The e-Clinical solutions market has become a pivotal component of the healthcare and pharmaceutical industries. E-Clinical solutions refer to a set of software, tools, and platforms designed to streamline clinical trials and healthcare management. These solutions include electronic data capture (EDC), clinical trial management systems (CTMS), laboratory information management systems (LIMS), and other integrated tools that improve the efficiency, accuracy, and speed of clinical trials and healthcare services. The primary
E-Clinical Solutions Market: Revolutionizing Clinical Trials
The e-clinical solutions market has experienced significant growth in recent years, driven by the increasing complexity of clinical trials and the need for efficient, accurate, and compliant data management. E-clinical solutions provide a comprehensive suite of tools and technologies to streamline clinical trial processes, accelerate drug development, and improve patient outcomes. Market Size and Growth The global e-clinical solutions market is estimated to be worth billions of dollars, with a significant portion
Clinical Trials Management System Market Optimizing Clinical Trials: The Crucial …
Clinical Trials Management System Market to reach over USD 5.06 billion by the year 2031- Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medical
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
E-Clinical Trial Solutions Market To Accelerating Clinical Development Technolog …
The study of the "Global e-Clinical Trial Solutions Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry. The Global e-Clinical Trial Solutions Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the e-Clinical